Clinical study of testicular germ cell tumors

Acta Urologica Japonica

Volumn 47, Issue 6, 2001, Pages 389-395

  Tomomasa, Hiroshi ^a   Shimizu, Hirofumi ^a   Sato, Satoshi ^a   Adachi, Yoichi ^a   Ashizawa, Yoshio ^a   Kamiyama, Yutaka ^a   Okano, Yoshinori ^a   Sato, Mika ^a   Yoshii, Takashi ^a   Iizumi, Tatsuo ^a   Umeda, Takashi ^a   Yazaki, Tsunetada ^a  

^a NONE

Author keywords

Clinical statistics; Testicular germ cell tumor; Treatment result; Tumor markers

Indexed keywords

IMMUNOSUPPRESSIVE ACID PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER STAGING; GERM CELL TUMOR; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; SURVIVAL RATE; TESTIS TUMOR; TREATMENT OUTCOME;

ADULT; COMBINED MODALITY THERAPY; GERMINOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; SURVIVAL RATE; TESTICULAR NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0042909173     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Einhorn LH : Treatment of testicular cancer : a new and improved model. J Clin Oncol 8: 1777-1781, 1990
2. Petersen PM, Skakebaek NE and Giwercman A: Gonadal function in men with testicular cancer: biological and clinical aspects. APMIS 106: 24-36, 1998
3. Japanese Urological Association, The Japanese Society of Pathology: General rule for clinical and pathological studies on testicular tumors, the 2nd edition. Kanehara, Tokyo, 1997
4. Dunphy CH, Ayala AG and Swanson DA : Clinical stage I nonseminomatous and mixed germ cell tumors of the testis. Cancer 62: 1202-1206, 1988
5. Studer UE, Fey MF, Calderoni A, et al. : Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer. Eur Urol 23: 444-449, 1993
6. Tsumatani K, Ozono S, Momose H, et al. : Clinical study of testicular cancer. Acta Urol Jpn 42: 943-950, 1996
7. Suzuki M, Mikata N and Imao S : Clinical study of 46 cases of testicular germ cell tumor. Nishinihon J Urol 62: 121-124, 2000
8. Yokoyama M, Nemoto K, Kanemura M, et al.: Treatment outcome on 52 patients with 53 testicular germ cell tumors. Acta Urol Jpn 44: 789-794, 1998
9. Richie JP: Neoplasms of the testis. In Walsh PC, et al. : Campbell's Urology. 7th ed. pp 2411-2452, Saunders, Philadelphia, 1998
10. Whitaker RH: Management of the undescended testis. Br J Hosp Med 4: 25-37, 1970
11. Ueda H, Takahashi N and Kawasaki T: The significance of tumor markers in patients with testicular tumors. Nishinihon J Urol 56: 1347-1352, 1994
12. Iizumi T, Amemiya H, Hata R, et al. : Serum levels of IAP, CEA and CA19-9 in patients with urological malignancies. Jpn J Urol 79: 1448-1452, 1988
13. Tomomasa H, Tanaka W, Ishida W, et al. : Clinicostatistical study on patients with renal cell carcinoma. Teikyo Med J 18: 313-320, 1995
14. Miki T, Saiki S, Kinouchi T, et al.: Immunosuppressive acidic protein in patients with testicular cancer. J Urol 137: 48-52, 1987
15. Warde P, Gospodarowicz MK, Panzarella T, et al. : Stage I testicular seminoma: results of adjuvant irradiation and surveillance. J Clin Oncol 13: 2255-2262, 1995
16. Moul JW, McCarthy WF, Fernandez EB, et al.: Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer. Cancer Res 54: 362-364, 1994
17. Sogani PC, Perrotti M, Herr HW, et al.: Clinical stage I testis cancer: long-term outcome of patients on surveillance. J Urol 159: 855-858, 1998
18. Einhorn LH and Donohue JP: Cis-diaminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Inter Med 87: 293-298, 1997
19. De Wit R, Storter G, Sleijfer DT, et al. : Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma : a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group. Br J Cancer 71: 1311-1314, 1995
20. Bosl GJ, Geller NL, Bajorin D, et al. : A randomized trial of etoposide+cisplatin versus vinblastine+ bleomycin+cisplatin+cyclophosphamide+dactinomycin in patients with good-prognosis germ cell tumors. J Clin Oncol 6: 1231-1238, 1988
21. Dodd PM, Motzer RJ and Bajorin DF: Poor-risk germ cell tumors : recent development. Urol Clin North Am 25: 485-493, 1998
22. Motzer RJ, Mzumdar M, Bajorin DF, et al. : High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. J Clin Oncol 15: 2546-2552, 1997
23. Hara I, Yamada Y, Miyake H, et al.: Clinical outcome of high-dose chemotherapy combined with peripheral blood stem cell transplantation for male germ cell tumors. Anticancer Drugs 10: 711-718, 1999